• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Wednesday, April 14, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

Serum Institute pauses COVID-19 vaccine trials in India

NE NOW NEWS by NE NOW NEWS
September 10, 2020 6:31 pm
COVID-19 vaccine

Representational image. Image credit: Times Now

Share on FacebookShare on Twitter

The Serum Institute of India (SII) on Thursday said that it was pausing the COVID-19 vaccine trials in the country– a day after the firm was issued a show-cause notice by the Drugs Controller General of India (DGCI).

In its notice, the DGCI VG Somani questioned SII about the reason of still proceeding with the trials of Oxford University’s Covishield vaccine after one of the volunteers who got a shot of the experimental vaccine in the UK showed some adverse reactions.

With the patient in the UK showing serious adverse reactions during the trial phase, AstraZeneca, which jointly developed the COVID-19 vaccine along with Oxford University, has now temporarily stopped the clinical trials of the Covishield vaccine in four nations as a precautionary measure.

The Pune-based vaccine manufacturer said that it is pausing the trials of the Covishield vaccine in India till AstraZeneca restarts them.

“We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following Drug Controller General of India’s (DGCI) instructions and will not be able to comment further on trials,”?SII said.

On Wednesday, the phase three trials of AstraZeneca were stopped in the UK and the pharma firm said it has halted global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

“We voluntarily paused vaccination to allow a review of safety data by an independent committee,” AstraZeneca said in a statement.

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” the statement added.

 

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd